Cardiologie - Prévention
0543.718.256 · rovalta.com · 26/09/2026
ACTIVE
Cardiologie - Prévention
Financial year 2025 · Closed on 31/12/2025
Net result92,9 k €-36,6 %over 1 year
Gross margin115,2 k €-37,9 %over 1 year
Equity326,3 k €-38,8 %over 1 year
Overview
Identity
Source · BCE/KBOCardiologie - Prévention is a Private limited company incorporated in 2014. Its main activity is: Specialist medical practice activities. Its registered office is in Namur.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0543.718.256
- Incorporation
- 02/01/2014
- Legal form
- Private limited company
- Registered office
- Avenue du Parc d'Andoy(WD) 21
5100 Namur · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2025 | 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 115,2 k € | -37.9% | 185,6 k € | +29.6% | 143,2 k € | -23.4% | 186,9 k € | +116% | 86,6 k € |
| EBITDA | 114,3 k € | -38.0% | 184,3 k € | +29.4% | 142,4 k € | -23.4% | 186 k € | +116% | 86,3 k € |
| Operating result | 113,6 k € | -38.3% | 184,3 k € | +34.0% | 137,5 k € | -18.8% | 169,3 k € | +143% | 69,7 k € |
| Net result | 92,9 k € | -36.6% | 146,4 k € | +51.6% | 96,6 k € | -16.3% | 115,4 k € | +139% | 48,3 k € |
| Balance sheet | |||||||||
| Equity | 326,3 k € | -38.8% | 533,1 k € | +15.4% | 461,8 k € | +5.0% | 439,8 k € | -10.1% | 488,9 k € |
| Total assets | 643,2 k € | +0.5% | 640 k € | +14.7% | 558 k € | -8.8% | 611,6 k € | +9.0% | 561 k € |
| Cash | 269 k € | -10.6% | 300,9 k € | +26.3% | 238,1 k € | -28.0% | 330,6 k € | -9.1% | 363,6 k € |
| Debts | 316,9 k € | +196% | 106,9 k € | +59.3% | 67,1 k € | -39.1% | 110,1 k € | +270% | 29,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
Céline Braeken
ActivePhilippe Boyazis
ActiveFinancials
Full financial information
Source · NBB| 2025 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/04/2025 | 01/04/2024 | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 |
| Closing of the financial year | 31/12/2025 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
| Length of the financial year | 9 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 20/11/2025 | 31/10/2024 | 31/10/2023 | 28/10/2022 | 28/10/2021 |
| General meeting | 25/06/2026 | 16/10/2025 | 27/09/2024 | 29/09/2023 | 30/09/2022 | 24/09/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 25/06/2026 | 30/06/2026 | French | |
| Micro model | 31/03/2025 | 16/10/2025 | 20/11/2025 | French | |
| Micro model | 31/03/2024 | 27/09/2024 | 31/10/2024 | French | |
| Micro model | 31/03/2023 | 29/09/2023 | 31/10/2023 | French | |
| Micro model | 31/03/2022 | 30/09/2022 | 28/10/2022 | French | |
| Micro model | 31/03/2021 | 24/09/2021 | 28/10/2021 | French | |
| Micro model | 31/03/2020 | 25/09/2020 | 27/11/2020 | French | |
| Micro model | 31/03/2019 | 27/09/2019 | 31/10/2019 | French | |
| Micro model | 31/03/2018 | 28/09/2018 | 31/10/2018 | French | |
| Micro model | 31/03/2017 | 30/09/2017 | 30/10/2017 | French | |
| Abridged model | 31/03/2016 | 30/09/2016 | 28/10/2016 | French | |
| Abridged model | 31/03/2015 | 25/09/2015 | 30/09/2015 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active
Active mandates
Céline Braeken
ActivePhilippe Boyazis
ActiveOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other06/03/2026ASSEMBLEE GENERALE - ANNEE COMPTABLE
- Mandates19/05/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS
- Registered office16/09/2016SIEGE SOCIAL
- Other13/01/2014RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202592,9 k €↓
- 2025Annual accounts 2025146,4 k €↑
- 2025Name changeSrl Cardiologie - Prévention
- 2024Annual accounts 202496,6 k €↓
- 2023Annual accounts 2023115,4 k €↑
- 2022Annual accounts 202248,3 k €↑
- 2022Name changeCardiologie et Prévention Dr Boyazis - Braeken
- 2021Annual accounts 202145,6 k €↓
- 2020Annual accounts 202060,4 k €↓
- 2019Annual accounts 201975,1 k €↑
- 2018Annual accounts 201874,5 k €↓
- 2017Annual accounts 201785,2 k €↑
- 2016Annual accounts 201679,3 k €↓
- 2015Annual accounts 2015133 k €
- 02/01/2014IncorporationPrivate limited company